trial
as of 2026-07-01Enhancing Synaptic Plasticity and Cognition in Schizophrenia
NCTId NCT01776112
at a glance
— · Completed
Enrollment 66 (actual)
Sponsored by University Medical Center Goettingen
Primary completion 2014-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
66 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2011-01
Primary completion
2014-03
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Drugs
Sponsors
University Medical Center GoettingenLead Sponsor
Investigators
3
Peter G. Falkai, Prof. Dr.Principal Investigator
Andrea Schmitt, MD, PhDStudy Director
Berend Malchow, MDStudy Director
Sites
1 total
Göttingen, Germany
Facts & assertions
4 sourced
Enrollment
66
Phase
NA
Primary Completion Date
2014-03
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
indication
investigator